Skip to content
Staging environment — review version. Do not share.

Research and InnovationResearch Radar

Study compares clinical outcomes in older adults prescribed 10 common antidepressants

Older adults with depression may be less likely to discontinue or change treatment when sertraline is first prescribed...

By João L. de Quevedo, MD, PhD

Published on · Last reviewed on · 2 min read

Older adults with depression may be less likely to discontinue or change treatment when sertraline is first prescribed, compared with other antidepressants, suggests a report in The American Journal of Psychiatry.

The study compared one-year outcomes in 93,000 Danish residents with depression who were prescribed one of 10 antidepressants for the first time. The research was funded in part by the Health Research Foundation of the Central Denmark Region.

“Although clinical trials are considered the gold standard for investigating drug efficacy, their experimental conditions often do not represent complex real-world scenarios, mainly because of the exclusion of vulnerable populations, such as older adults and individuals with comorbidities,” wrote Kazi Ishtiak-Ahmed, Ph.D., of Aarhus University Hospital in Denmark. “Therefore, real-world data are essential and complementary to these clinical trials, especially for older patients.”

Using Danish national registries, the researchers identified adults aged 65 years or older who filled a prescription for one of the 10 most frequently prescribed antidepressants at a community pharmacy for the first time between 2006 and 2017. Adults who were initially prescribed more than one antidepressant and/or received their first prescription in an inpatient hospital were excluded.

The final sample included 93,833 older Danish adults (mean age, 78 years) who started one of the following medications:

  • The selective serotonin reuptake inhibitors citalopram, escitalopram, fluoxetine, paroxetine, or sertraline
  • The serotonin-norepinephrine reuptake inhibitors duloxetine or venlafaxine
  • The tricyclic antidepressant amitriptyline
  • The atypical antidepressants mianserin or mirtazapine

The researchers tracked patient outcomes for one year after the first antidepressant prescription. These outcomes included the following:

  • Antidepressant discontinuation, augmentation, and/or switching
  • Outpatient, inpatient, and/or emergency psychiatric visits
  • Suicide attempt and/or self-harm
  • Fall-related injuries
  • Cardiovascular events
  • All-cause mortality

The researchers compared patient outcomes in each antidepressant group with those in the sertraline group (sertraline is recommended as the only first-choice treatment for depression in current Danish guidelines).

Compared with sertraline, most of the other nine antidepressants were associated with a significantly higher risk of adverse outcomes, with venlafaxine, mirtazapine, and escitalopram showing higher numbers of adverse clinical outcomes. Citalopram was associated with a lower risk of medication augmentation and psychiatric emergency or inpatient visits than sertraline, while amitriptyline was associated with fewer fall-related injuries and a lower risk of any psychiatric visit.

“Overall, our findings are consistent with existing Danish guidelines recommending sertraline as the first choice for the pharmacological treatment of depression in older adults and highlight the importance of carefully selecting antidepressant treatment in the initial pharmacological treatment of depression in older patients,” Ishtiak-Ahmed and colleagues concluded.

To read more on this topic, see the Psychiatric News article “Add-On Aripiprazole May Benefit Older Adults With Refractory Depression.”

Related content

Mood Disorders

The Intersection of Depression and ASD

Depression is a heavy burden for anyone, but for individuals on the autism spectrum, its weight can be particularly...

· Article